SCHEMBL22365025

SCHEMBL22365025

Fc1ncc(C2CC2)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12685102 0.73 — —
SCHEMBL19077856 0.68 KDM1A (0.35) —
SCHEMBL28576254 0.68 BRS3 (0.35) —
SCHEMBL15747143 0.67 TSHR (0.36) —
SCHEMBL30364270 0.66 GSK3B (0.41) —
SCHEMBL19087011 0.65 NPY5R (0.41) —
SCHEMBL15372087 0.65 NPY5R (0.45) —
SCHEMBL17571952 0.65 NPY5R (0.45) —
SCHEMBL15586080 0.63 F10 (0.35) —
SCHEMBL19116608 0.61 BRS3 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3792256-A1 PYRIDINE AND PYRIDIMINE COMPOUNDS AS PI3K-GAMMA INHIBITORS Incyte Corporation (US) 2021-03-17 — — EP disclosed
EP-3400221-B1 PYRAZOL / IMIDAZOL SUBSTITUTED PYRIDINES AS PI3K-GAMMA INHIBITORS INCYTE CORP (US) 2020-08-26 — — EP disclosed
Send feedback